Putting it in a nutshell, we see no short-term catalysts for share price appreciation. And we believe that there is even a downside risk, because of the lack of equilibrium in either EBITDA generation or net profit (including the equity-accounted Mexico), with too much exposure to North America. Consequently, following this trading update, we will lower our target price, which could lead to a change in recommendation from Add to Reduce.
